Timmermann C

Experimental Psychology, University College London, London, UK; DMT Research Group, Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College, London, UK.

29 preprints · 64 papers · ORCID

PreprintLSD

Serotonergic psychedelics delay resting state neurovascular coupling dynamics

Mundel L, Medel V, Timmermann C +9

Europe PMC2026
PreprintPsilocybin

Psychedelics restructure information in the human brain

Blackburne G, Liardi A, Mallaroni P +6

Europe PMC2026
PreprintDMT

Spiral brain dynamics track the temporal unfolding of subjective intensity during the <i>N,N</i> -dimethyltryptamine experience

Sawicka G, Martínez-Marín M, Timmermann C +5

Europe PMC2026
ArticleDMT

Higher signal diversity, network dysregulation, and increased well-being under DMT administration: An EEG study.

Kroupi E, Araujo H, Oosterveld C +5

Europe PMC2026
ArticlePsilocybin

On the meaning of "plasticity" in neuroscience and mental health research and its relation to the action of psychedelic therapy.

Carhart-Harris RL, Zeifman RJ, Pasquini L +8

Europe PMC2026
ArticlePsilocybin

Defining 'psychedelic'.

Ostrand AE, Nour MM, Timmermann C +7

Europe PMC2026
ArticleDMT

Micro-phenomenology of immersion and perceived presences under DMT.

Sanders JW, Millière R, Demšar E +4

Europe PMC2026
PreprintPsychedelics

A Shared Entropic Axis Spans States of Consciousness Across Pharmacological and Clinical Conditions

Galvan Rial DS, Della Bella GA, Naci L +8

Europe PMC2026
ArticleDMT

Computational spirits: a neuroscientific account of psychedelic entity encounters.

Mago J, Deane G, Sandved-Smith L +7

Europe PMC2026
PreprintPsilocybin

Reorganization of Human Brain Waves Across Diverse States of Consciousness

Fotiadis P, Jang H, Dai R +6

Europe PMC2026
PreprintPsychedelics

On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy

Carhart-Harris R, Zeifman R, Pasquini L +8

Europe PMC2026
ArticlePsilocybin

Human brain changes after first psilocybin use.

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2026
ArticlePsychedelics

Autonomic indicators of self-transcendence: insights from the numadelic VR paradigm.

Bonnelle V, Parola G, Andreu C +6

Europe PMC2026
ArticlePsilocybin

An international mega-analysis of psychedelic drug effects on brain circuit function.

Girn M, Doss MK, Roseman L +24

Europe PMC2026
ArticlePsychedelics

How to set up a psychedelic study: Unique considerations for research involving human participants.

Glennon MJ, Bird CIV, Yadav P +18

Europe PMC2026
ArticlePsilocybin

Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.

McAlpine R, Jaglinska M, Jedlovszky K +7

Europe PMC2026
ArticleDMT

A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

Erritzoe D, Barba T, Benway T +15

Europe PMC2026
ArticleDMT

DMT-Induced Shifts in Criticality Correlate with Self-Dissolution.

Irrmischer M, Aqil M, Luan L +5

Europe PMC2026
ArticlePsychedelics

Correction: Exploring practitioners' perceptions of health behavior changes associated with psychedelic experiences.

Carvalho LC, Encantado J, van Elk M +5

Europe PMC2025
PreprintPsilocybin

Defining ‘psychedelic’

Ostrand A, Nour M, Timmermann C +7

Europe PMC2025
PreprintPsilocybin

A Mesoscale Framework for Psychedelic Drug Action in the Human Brain

Dai R, Cofre R, Timmermann C +4

Europe PMC2025
ArticlePsychedelics

Exploring practitioners' perceptions of health behavior changes associated with psychedelic experiences.

Carvalho LC, Encantado J, van Elk M +5

Europe PMC2025
PreprintPsychedelics

Autonomic Indicators of Self-Transcendence: Insights from the Numadelic VR Paradigm

Bonnelle V, Parola G, Andreu C +6

Europe PMC2025
ArticleDMT

Reactivations Associated with the Use of 5-MeO-DMT Among Spanish-Speaking Individuals: Prevalence, Predictors, and Emotional Valence.

Ortiz Bernal AM, Raison CL, Lancelotta RL +3

Europe PMC2025
PreprintDMT

Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner

Timmermann C, Barba T, Sanders J +4

Europe PMC2025
PreprintDMT

Neural effects and phenomenology of nondual meditation and 5-MeO-DMT in an expert meditation practitioner

Timmermann C, Barba T, Sanders J +4

Europe PMC2025
ArticlePsilocybin

N,N-dimethyltryptamine effects on connectome harmonics, subjective experience and comparative psychedelic experiences.

Vohryzek J, Luppi AI, Atasoy S +4

Europe PMC2025
ArticlePsilocybin

A Scoping Review of Research in Naturalistic Studies with Psychedelics.

Carvalho LC, Encantado J, Kettner H +3

Europe PMC2025
PreprintDMT

Micro-phenomenology of immersion and perceived presences under DMT

Sanders JW, Millière R, Demšar E +3

Europe PMC2025
ArticlePsilocybin

Effects of psychedelics on human oscillatory brain activity.

Godfrey K, Luan LX, Timmermann C

Europe PMC2025
ArticleDMT

Exploring 5-MeO-DMT as a pharmacological model for deconstructed consciousness.

Timmermann C, Sanders JW, Reydellet D +16

Europe PMC2025
ArticleDMT

Network control energy reductions under DMT relate to serotonin receptors, signal diversity, and subjective experience.

Singleton SP, Timmermann C, Luppi AI +4

Europe PMC2025
ArticleDMT

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self.

Pasquini L, Simon AJ, Gallen CL +5

Europe PMC2025
ArticleDMT

Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT).

Piccinini JI, Sanz Perl Y, Pallavicini C +6

Europe PMC2025
PreprintDMT

DMT-induced shifts in criticality correlate with ego-dissolution

Irrmischer M, Aqil M, Luan L +5

Europe PMC2025
PreprintPsychedelics

Practitioner perspectives on meditation-based preparation for psychedelic experiences

McAlpine R, Utanğaç M, Kuc J +8

Europe PMC2025
PreprintPsilocybin

Brain dynamics of classical psychedelics show paradoxical hierarchical flattening with increased complexity

Vohryzek J, Garcia Guzman E, Kringelbach ML +8

Europe PMC2024
PreprintPsilocybin

Human brain changes after first psilocybin use

Lyons T, Spriggs M, Kerkelä L +20

Europe PMC2024
ArticlePsilocybin

Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Erritzoe D, Barba T, Greenway KT +9

Europe PMC2024
ArticleDMT

Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being.

Bonnelle V, Feilding A, Rosas FE +3

Europe PMC2024
ArticlePsilocybin

Within-subject comparison of near-death and psychedelic experiences: acute and enduring effects.

Martial C, Carhart-Harris R, Timmermann C

Europe PMC2024
ArticlePsychedelics

An Integrated theory of false insights and beliefs under psychedelics.

McGovern HT, Grimmer HJ, Doss MK +5

Europe PMC2024
ArticlePsychedelics

Interrupting the Psychedelic Experience Through Contextual Manipulation to Study Experience Efficacy.

Roseman L, Erritzoe D, Nutt D +2

Europe PMC2024
PreprintDMT

Time-resolved coupling between connectome harmonics and subjective experience under the psychedelic DMT

Vohryzek J, Luppi A, Atasoy S +4

Europe PMC2024
ArticlePsilocybin

Psychedelics and the 'inner healer': Myth or mechanism?

Peill J, Marguilho M, Erritzoe D +5

Europe PMC2024
ArticleDMT

The flattening of spacetime hierarchy of the <i>N,N</i>-dimethyltryptamine brain state is characterized by harmonic decomposition of spacetime (HADES) framework.

Vohryzek J, Cabral J, Timmermann C +6

Europe PMC2024
PreprintDMT

Autonomic Nervous System activity correlates with peak experiences induced by DMT and predicts increases in wellbeing

Bonnelle V, Feilding A, Rosas FE +3

Europe PMC2024
PreprintDMT

Dynamic medial parietal and hippocampal deactivations under DMT relate to sympathetic output and altered sense of time, space, and the self

Pasquini L, Simon AJ, Gallen CL +5

Europe PMC2024
ArticleDMT

Effects of DMT on mental health outcomes in healthy volunteers.

Timmermann C, Zeifman RJ, Erritzoe D +2

Europe PMC2024
PreprintDMT

Transient destabilization of whole brain dynamics induced by DMT

Piccinini JI, Perl YS, Pallavicini C +6

Europe PMC2024
ArticleLSD

Effects of External Stimulation on Psychedelic State Neurodynamics.

Mediano PAM, Rosas FE, Timmermann C +10

Europe PMC2024
ArticleDMT

Safety, tolerability, pharmacodynamic and wellbeing effects of SPL026 (dimethyltryptamine fumarate) in healthy participants: a randomized, placebo-controlled phase 1 trial.

James E, Erritzoe D, Benway T +12

Europe PMC2023
PreprintPsilocybin

The entropic heart: Tracking the psychedelic state via heart rate dynamics

Rosas FE, Mediano PA, Timmermann C +9

Europe PMC2023
ArticleDMT

Psychological and physiological effects of extended DMT.

Luan LX, Eckernäs E, Ashton M +10

Europe PMC2024
ArticleLSD

LSD-induced changes in the functional connectivity of distinct thalamic nuclei.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +10

Europe PMC2023
ArticleDMT

Optimized infusion rates for N,N-dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework.

Eckernäs E, Koomen J, Timmermann C +3

Europe PMC2023
PreprintDMT

Harmonic decomposition of spacetime (HADES) framework characterises the spacetime hierarchy of the DMT brain state

Vohryzek J, Cabral J, Timmermann C +6

Europe PMC2023
ArticlePsilocybin

Translation and Initial Psychometric Evaluation of Spanish Versions of Three Psychedelic Acute Effects Measures: Mystical, Challenging, and Insight Experiences.

Davis AK, Timmermann C, Ortiz Bernal AM +5

Europe PMC2024
ArticleDMT

N, N-Dimethyltryptamine (DMT)-Occasioned Familiarity and the Sense of Familiarity Questionnaire (SOF-Q).

Lawrence DW, DiBattista AP, Timmermann C

Europe PMC2024
ArticlePsilocybin

In vivo mapping of pharmacologically induced functional reorganization onto the human brain's neurotransmitter landscape.

Luppi AI, Hansen JY, Adapa R +23

Europe PMC2023
PreprintDMT

Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience

Singleton SP, Timmermann C, Luppi AI +4

Europe PMC2023
ArticleDMT

Pharmacokinetics of N,N-dimethyltryptamine in Humans.

Good M, Joel Z, Benway T +9

Europe PMC2023
PreprintDMT

Psychological and physiological effects of extended DMT

Luan LX, Eckernäs E, Ashton M +10

Europe PMC2023
ArticleLSD

Spatial Correspondence of LSD-Induced Variations on Brain Functioning at Rest With Serotonin Receptor Expression.

Delli Pizzi S, Chiacchiaretta P, Sestieri C +8

Europe PMC2023
ArticleDMT

Human brain effects of DMT assessed via EEG-fMRI.

Timmermann C, Roseman L, Haridas S +12

Europe PMC2023
ArticlePsilocybin

Default Mode Network Modulation by Psychedelics: A Systematic Review.

Gattuso JJ, Perkins D, Ruffell S +11

Europe PMC2023
ArticleDMT

N,N-dimethyltryptamine affects electroencephalography response in a concentration-dependent manner-A pharmacokinetic/pharmacodynamic analysis.

Eckernäs E, Timmermann C, Carhart-Harris R +2

Europe PMC2023
ArticlePsilocybin

Canalization and plasticity in psychopathology.

Carhart-Harris RL, Chandaria S, Erritzoe DE +11

Europe PMC2023
ArticlePsilocybin

Body mass index (BMI) does not predict responses to psilocybin.

Spriggs MJ, Giribaldi B, Lyons T +9

Europe PMC2023
ArticlePsilocybin

Effects of classic psychedelic drugs on turbulent signatures in brain dynamics.

Cruzat J, Perl YS, Escrichs A +10

Europe PMC2022
ArticleDMT

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N-dimethyltryptamine - Implications for dose considerations.

Eckernäs E, Timmermann C, Carhart-Harris R +2

Europe PMC2022
ArticlePsilocybin

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

Watts R, Kettner H, Geerts D +9

Europe PMC2022
PreprintPsilocybin

Mapping Pharmacologically-induced Functional Reorganisation onto the Brain’s Neurotransmitter Landscape

Luppi AI, Hansen JY, Adapa R +24

Europe PMC2022
ArticleDMT

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience.

Lawrence DW, Carhart-Harris R, Griffiths R +1

Europe PMC2022
PreprintDMT

PHARMACOKINETICS OF N,N-DIMETHYLTRYPTAMINE FUMARATE IN HUMANS

Good M, Benway T, Joel Z +9

Europe PMC2022
PreprintDMT

Phenomenology and Content of the Inhaled N, N-Dimethyltryptamine (N, N-DMT) Experience

Lawrence DW, Carhart-Harris R, Griffiths R +1

Europe PMC2022
ArticlePsilocybin

Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.

Timmermann C, Watts R, Dupuis D

Europe PMC2022
ArticleDMT

Development and application of a highly sensitive LC-MS/MS method for simultaneous quantification of N,N-dimethyltryptamine and two of its metabolites in human plasma.

Eckernäs E, Bendrioua A, Cancellerini C +4

Europe PMC2022
ArticlePsychedelics

Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience.

Peill JM, Trinci KE, Kettner H +6

Europe PMC2022
ArticlePsychedelics

Psychedelics alter metaphysical beliefs.

Timmermann C, Kettner H, Letheby C +3

Europe PMC2021
ArticlePsilocybin

Psychedelics and health behaviour change.

Teixeira PJ, Johnson MW, Timmermann C +5

Europe PMC2022
ArticleMescaline

The epidemiology of mescaline use: Pattern of use, motivations for consumption, and perceived consequences, benefits, and acute and enduring subjective effects.

Uthaug MV, Davis AK, Haas TF +5

Europe PMC2022
ArticlePsychedelics

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness.

Kettner H, Rosas FE, Timmermann C +3

Europe PMC2021
ArticlePsychedelics

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing.

Kaertner LS, Steinborn MB, Kettner H +7

Europe PMC2021
ArticleDMT

Neural network models for DMT-induced visual hallucinations.

Schartner MM, Timmermann C

Europe PMC2020
ArticleDMT

DMT alters cortical travelling waves.

Alamia A, Timmermann C, Nutt DJ +2

Europe PMC2020
PreprintDMT

Neural and subjective effects of inhaled DMT in natural settings

Pallavicini C, Cavanna F, Zamberlan F +7

Europe PMC2020
ArticlePsychedelics

The potential synergistic effects between psychedelic administration and nature contact for the improvement of mental health.

Gandy S, Forstmann M, Carhart-Harris RL +3

Europe PMC2020
PreprintDMT

DMT alters cortical travelling waves

Alamia A, Timmermann C, VanRullen R +1

Europe PMC2020
ArticleDMT

Neural correlates of the DMT experience assessed with multivariate EEG.

Timmermann C, Roseman L, Schartner M +13

Europe PMC2019
ArticlePsychedelics

Predicting Responses to Psychedelics: A Prospective Study.

Haijen ECHM, Kaelen M, Roseman L +8

Europe PMC2018
ArticleDMT

DMT Models the Near-Death Experience.

Timmermann C, Roseman L, Williams L +6

Europe PMC2018
ArticleLSD

LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm.

Timmermann C, Spriggs MJ, Kaelen M +5

Europe PMC2018